BRISTOL-MYERS SQUIBB COMPANY

Official Publications Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Market Closed - Nyse Other stock markets 01:30:01 14/05/2024 am IST			5-day change	1st Jan Change
45.06 ^USD	+0.27%		+2.64%	-12.18%

10/05	Bristol-Myers Squibb Says Phase 3 Trial of Opdivo in Lung Cancer Fails to Meet Primary Endpoint	MT
10/05	Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint	DJ

Official Publications

Slide show Q1	27/23/27	CO
1st quarter results	27/23/27	CO
Annual Report	27/23/27	CO
SEC Filing 8K	27/23/27	CO
SEC Filing 8K	26/23/26	CO
Proxy Statments	23/23/23	CO
SEC Filing 10K	14/23/14	CO
Slide show results	02/23/02	CO
Annual results	02/23/02	CO
SEC Filing 8K	02/23/02	CO
SEC Filing 8K	31/23/31	CO
SEC Filing 8K	09/23/09	CO
Slide show Q3	26/22/26	CO
3rd quarter results	26/22/26	CO
SEC Filing 10Q-2	26/22/26	CO
SEC Filing 8K	26/22/26	CO
SEC Filing 8K	27/22/27	CO
SEC Filing 10Q-2	27/22/27	CO
1st-half-year results	27/22/27	CO
Slide show half-year results	27/22/27	CO
SEC Filing 4K	16/22/16	CO
SEC Filing 8K	15/22/15	CO
Dividends	15/22/15	CO
Slide show Q1	29/22/29	CO
1st quarter results	29/22/29	CO

1 2 3

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Headlines

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

January 09, 2024 at 11:36 pm IST

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW